Bloomington, IN – Another Bloomington facility will be producing COVID-19 vaccines.

Baxter International Inc. recently announced a deal with Moderna to produce 60-90 million doses of COVID-19 vaccines by year’s end. Baxter BioPharma Solutions will provide fill/finish sterile manufacturing services and supply packaging from its Bloomington facilities. Catalent is also producing Moderna’s COVID-19 vaccine at its Bloomington facilities.

Baxter’s BioPharma Solutions business is a contract manufacturing organization specializing in injectable pharmaceuticals, including vaccines, according to a news release from the company. The site has capabilities and expertise in injectable delivery systems as well as clinical and commercial vaccine manufacturing.